# US 2024/0200124 A1 · Compositions and methods for performing hybridizations with no denaturation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0200124 A1
- Document ID: US20240200124A1
- Status: Published application
- Kind: A1
- Application number: 18/540,512
- Filed: 2023-12-14
- Published: 2024-06-20
- Earliest claimed: 2009-12-02
- Assignees: Agilent Technologies, Inc.
- Applicants: Agilent Technologies, Inc.
- Inventors: Steen H. Matthiesen
- Web page: https://patentgrep.com/patent/US20240200124A1

## CPC

- C12Q 1/6832: Enhancement of hybridisation reaction
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention provides methods and compositions for hybridizing at least one molecule to a target. The invention may, for example, eliminate the use of, or reduce the dependence on formamide in hybridization. Compositions for use in the invention include an aqueous composition comprising at least one nucleic acid sequence and at least one polar aprotic solvent in an amount effective to denature double-stranded nucleotide sequences.

## Claims

### Claim at position 1

1-60. (canceled)

### Claim 61

A method of hybridizing nucleic acid sequences without a denaturation step comprising:
providing a first nucleic acid sequence within a cell in a sample having a preserved cell morphology,
providing a second nucleic acid sequence, wherein one or both of the first and second nucleic acid sequences are double stranded,
providing a hybridization composition comprising an effective amount of at least one polar aprotic solvent to enable hybridization, and 10-80% of an accelerating agent, and
combining the first nucleic acid sequence, the second nucleic acid sequence, and the hybridization composition for at least a time period sufficient to hybridize the first and second nucleic acid sequences within the cell such that the first and second nucleic acid sequences hybridize within the cell and the sample morphology is preserved, and wherein the hybridization process is performed within 4 hours,
wherein the at least one polar aprotic solvent is selected from the group consisting of:
and
with the proviso that the hybridization composition does not contain formamide.

### Claim 62 (depends on 61)

The method according to claim 61, wherein the first nucleic acid sequence is in a cytology or histology sample.

### Claim 63 (depends on 61)

The method according to claim 61, wherein the first nucleic acid sequence is a single stranded sequence and the second nucleic acid sequence is a double stranded sequence.

### Claim 64 (depends on 61)

The method according to claim 61, wherein the first nucleic acid sequence is a double stranded sequence in a biological sample and the second nucleic acid sequence is a single stranded sequence.

### Claim 65 (depends on 61)

The method according to claim 61, wherein the first and second nucleic acid sequences are double stranded sequences.

### Claim 66 (depends on 61)

The method according to claim 61, wherein the combining further comprises heating and cooling the hybridization composition and nucleic acid sequences.

### Claim 67 (depends on 61)

The method according to claim 61, wherein the time period sufficient to hybridize the first and second nucleic acid sequences within the cell is less than 1 hour.

### Claim 68 (depends on 67)

The method according to claim 67, wherein the time period is less than 30 minutes.

### Claim 69 (depends on 68)

The method according to claim 68, wherein the time period is less than 15 minutes.

### Claim 70 (depends on 69)

The method according to claim 69, wherein the time period is less than 5 minutes.

### Claim 71 (depends on 61)

The method according to claim 61, wherein the concentration of polar aprotic solvent is 5% to 10% (v/v).

### Claim 72 (depends on 61)

The method according to claim 61, wherein the concentration of polar aprotic solvent is 10% to 20% (v/v).

### Claim 73 (depends on 61)

The method according to claim 61, wherein the concentration of polar aprotic solvent is 20% to 30% (v/v).

### Claim 74 (depends on 61)

The method according to claim 61, wherein the polar aprotic solvent in the hybridization composition is:

### Claim 75 (depends on 61)

The method according to claim 61, wherein the accelerating agent is dextran sulfate.

### Claim 76 (depends on 75)

The hybridization composition according to claim 75, wherein the composition comprises from 5% to 40% by weight dextran sulfate.

### Claim 77 (depends on 75)

The hybridization composition according to claim 75, wherein the composition comprises from 10% to 20% by weight dextran sulfate.
